<u>Answer</u>:
It makes the kinetics of the complex so rapid as to prevent it from being the rate-limiting step(s) of a pathway is not true regarding substrate channelling
<u>Explanation</u>:
Substrate channelling is the transfer of transitional metabolic products of one enzyme straightly to other enzyme or any active site without its release into solution.The metabolic pathway can be made more rapid and also efficient than it would actually be through channelling if enzymes could have been randomly designed. It occurs in many ways like in pyruvate dehydrogenase complex may be tryptophan synthase or can be dihydrofolate reductase thymidylate synthase.
Answer:
minerals are not man-made. They are naturally occurring. Minerals concocted in the the lab do not count although there are about 208 man made minerals discovered around mines
It seem like there are information missing on the question posted. Let me answer this question with all I know. So here is what I believe the answer is, the catalyst has acted upon it.
Hope my answer would be a great help for you. If you have more questions feel free to ask here at Brainly.
Monoclonal antibodies are made by the fusion of cells of the immune system with B lymphocytes and myeloma cells.
<h3>What is Hybridoma technology?</h3>
- It is one of the best technologies that is used to produce the monoclonal antibody.
- In this hybridoma technology the B lymphocytes that are antibody producing are isolated from a source after the immunization with a specific antigen and then are fused with myeloma cell line to form hybrid cells that are also called as hybridoma cell lines.
- The hybridoma cell lines are then cultured in the laboratory with specific antigen and then the monoclonal antibodies are produced.
- This can be done in in-vivo or in-vitro condition.
- This method is preferred over all because the production of antibodies by this method is good as the antibodies produced are of high purity and highly sensitive and specific.
- These cell lines can also be preserved for a long time.
- Hybridoma technology has resulted in production of different varieties of monoclonal antibodies with specificity with specific antigens as the monoclonal antibodies are produced by single parental B cells.
To know more about Antibodies visit:
brainly.com/question/13299860
#SPJ4
